Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Caprylic Aldehyde
1. 124-13-0
2. Caprylaldehyde
3. Caprylic Aldehyde
4. N-octanal
5. 1-octanal
6. N-octyl Aldehyde
7. N-octaldehyde
8. N-caprylaldehyde
9. Octanaldehyde
10. Octyl Aldehyde
11. N-octylal
12. Aldehyde C-8
13. Octanoic Aldehyde
14. Octylaldehyde
15. C-8 Aldehyde
16. Octaldehyde
17. 1-octylaldehyde
18. 1-octaldehyde
19. 1-caprylaldehyde
20. Aldehyde C8
21. N-octanaldehyde
22. Antifoam-lf
23. Oktylaldehyd
24. Oktanal
25. Octanal, Tech.
26. Caprylaldehyd
27. Fema No. 2797
28. Kaprylaldehyd
29. Octylaldehyd
30. Nsc 1508
31. Aldehido C-8
32. Chembl18407
33. Chebi:17935
34. Nsc1508
35. Xge9999h19
36. Nsc-1508
37. Nsc-8969
38. Dsstox_cid_1643
39. Wln: Vh7
40. Dsstox_rid_76257
41. Dsstox_gsid_21643
42. Octanal (natural)
43. Albumin Tannate
44. Octyl Aldehydes
45. Cas-124-13-0
46. Hsdb 5147
47. Einecs 204-683-8
48. Mfcd00007029
49. Brn 1744086
50. N-octylaldehyde
51. Capryl Aldehyde
52. Unii-xge9999h19
53. Ai3-03961
54. N -octanal
55. Octan-1-one
56. Octan-8-one
57. Oya
58. Octanal, 99%
59. Octanal [fcc]
60. N-octanal [fhfi]
61. Bmse000851
62. Ec 204-683-8
63. Octanal, Analytical Standard
64. Octylaldehyde [hsdb]
65. Schembl28601
66. 4-01-00-03337 (beilstein Handbook Reference)
67. Caprylic Aldehyde [mi]
68. Qspl 183
69. Dtxsid3021643
70. Octanal (aldehyde C-8)
71. Nsc8969
72. Octanal, >=95%, Fcc, Fg
73. Hy-n8015
74. Str04459
75. Zinc1529222
76. Tox21_201415
77. Tox21_300337
78. Bdbm50028817
79. Lmfa06000028
80. Akos009031567
81. Octanal, Natural, >=95%, Fcc, Fg
82. Ncgc00247997-01
83. Ncgc00247997-02
84. Ncgc00254427-01
85. Ncgc00258966-01
86. Cs-0138976
87. Ft-0626917
88. Ft-0631629
89. Ft-0631722
90. Ft-0673199
91. O0044
92. En300-19768
93. C01545
94. Q416673
95. J-660019
96. Q-200605
97. 27457-18-7
| Molecular Weight | 128.21 g/mol |
|---|---|
| Molecular Formula | C8H16O |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 6 |
| Exact Mass | 128.120115130 g/mol |
| Monoisotopic Mass | 128.120115130 g/mol |
| Topological Polar Surface Area | 17.1 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 59.6 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents
A07X - Other antidiarrheals
A07XA - Other antidiarrheals
A07XA01 - Albumin tannate
Rats were nose exposed to an atmosphere containing 11.4 ppm of (11)C-octanal for 2 min. Inhaled octanal was absorbed from the lungs in a biphasic manner and the greatest concentration of octanal occurred in most tissues at 5 min. Tissue activities calculated on the basis of the administered dose and on the radiolabel retained until the animal was killed indicated a redistribution of the radiolabel as metabolic products after 20 min. The labeled carbon was eliminated in a biphasic manner as (11)CO2, which accounted for essentially all of the activity lost by the exposed rats.
PMID:6114832 Kutzman RS et al; Drug Metab Dispos 9 (4): 331-3 (1981)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Octanal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Octanal, including repackagers and relabelers. The FDA regulates Octanal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Octanal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Octanal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Octanal supplier is an individual or a company that provides Octanal active pharmaceutical ingredient (API) or Octanal finished formulations upon request. The Octanal suppliers may include Octanal API manufacturers, exporters, distributors and traders.
click here to find a list of Octanal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Octanal DMF (Drug Master File) is a document detailing the whole manufacturing process of Octanal active pharmaceutical ingredient (API) in detail. Different forms of Octanal DMFs exist exist since differing nations have different regulations, such as Octanal USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Octanal DMF submitted to regulatory agencies in the US is known as a USDMF. Octanal USDMF includes data on Octanal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Octanal USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Octanal suppliers with USDMF on PharmaCompass.
Octanal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Octanal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Octanal GMP manufacturer or Octanal GMP API supplier for your needs.
A Octanal CoA (Certificate of Analysis) is a formal document that attests to Octanal's compliance with Octanal specifications and serves as a tool for batch-level quality control.
Octanal CoA mostly includes findings from lab analyses of a specific batch. For each Octanal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Octanal may be tested according to a variety of international standards, such as European Pharmacopoeia (Octanal EP), Octanal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Octanal USP).
LOOKING FOR A SUPPLIER?
